Tanja Schirmeister Selected Research

Protease Inhibitors (Protease Inhibitor)

1/2022	Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin Analogues.
10/2005	Comparison of the separation of aziridine isomers applying heptakis(2,3-di-O-methyl-6-sulfato)beta-CD and heptakis(2,3-di-O-acetyl-6-sulfato)beta-CD in aqueous and nonaqueous systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tanja Schirmeister Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 04/2014
14	African Trypanosomiasis (Nagana) 05/2023 - 09/2009
8	Infections 01/2024 - 07/2006
7	Malaria 04/2024 - 04/2008
6	COVID-19 10/2023 - 01/2022
5	Leukemia 12/2023 - 03/2017
3	Parasitic Diseases (Parasitic Disease) 08/2022 - 10/2005
3	Leishmaniasis 01/2018 - 07/2006
3	Multiple Myeloma 10/2016 - 04/2014
3	Severe Acute Respiratory Syndrome 09/2014 - 11/2005
2	Chagas Disease (American Trypanosomiasis) 05/2023 - 01/2018
2	Neglected Diseases 11/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2017
2	Coronavirus Infections 12/2005 - 11/2005
1	Schistosomiasis (Bilharziasis) 04/2024
1	Multiple Sclerosis 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Community-Acquired Infections 01/2020
1	Dengue (Dengue Fever) 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2014
1	Melanoma (Melanoma, Malignant) 08/2014
1	Lymphoma (Lymphomas) 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 06/2013
1	Rupture 12/2010
1	Falciparum Malaria (Plasmodium falciparum Malaria) 09/2009
1	Autolysis 07/2009

Drug/Important Bio-Agent (IBA)

19	Cysteine Proteases (Cysteine Protease)IBA 10/2023 - 01/2006
17	rhodesainIBA 04/2024 - 09/2009
8	EnzymesIBA 01/2024 - 01/2006
7	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 11/2005
6	falcipain 2IBA 04/2024 - 07/2010
5	Antiviral Agents (Antivirals)IBA 11/2023 - 09/2014
5	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2020 - 06/2013
4	Cathepsin LIBA 01/2024 - 01/2017
4	PeptidomimeticsIBA 01/2022 - 07/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 01/2022
3	methylcobalamin-coenzyme M methyltransferaseIBA 06/2023 - 01/2022
3	Peptides (Polypeptides)IBA 06/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
2	MetalsIBA 10/2023 - 09/2020
2	Antineoplastic Agents (Antineoplastics)IBA 10/2023 - 08/2014
2	RNA (Ribonucleic Acid)IBA 06/2023 - 11/2022
2	cruzipainIBA 05/2023 - 01/2018
2	cathepsin SIBA 01/2023 - 01/2020
2	CathepsinsIBA 08/2022 - 09/2015
2	Serine Proteases (Serine Protease)IBA 01/2022 - 12/2019
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 10/2005
2	EstersIBA 03/2017 - 07/2010
2	Cathepsin BIBA 01/2017 - 09/2014
1	Dihydrotachysterol (AT 10)IBA 04/2024
1	NitrilesIBA 04/2024
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	salicylaldehydeIBA 12/2023
1	LigandsIBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	HalogensIBA 10/2023
1	PalladiumIBA 10/2023
1	ChlorineIBA 10/2023
1	Schiff Bases (Schiff Base)IBA 10/2023
1	IodineIBA 10/2023
1	Monoclonal AntibodiesIBA 03/2023
1	VaccinesIBA 02/2023
1	Chymotrypsin FDA Link 01/2023
1	Amino Acids FDA Link 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	S-AdenosylhomocysteineIBA 11/2022
1	MethyltransferasesIBA 11/2022
1	Histone MethyltransferasesIBA 11/2022
1	Proteasome InhibitorsIBA 10/2022
1	aziridine (ethyleneimine)IBA 10/2022
1	Alkylating AgentsIBA 10/2022
1	camostatIBA 01/2022
1	PapainIBA 01/2021
1	UbiquitinIBA 09/2020
1	GoldIBA 09/2020
1	SilverIBA 09/2020
1	Auranofin (Ridaura)FDA Link 09/2020
1	KetonesIBA 12/2019
1	Antiparasitic Agents (Antiparasitics)IBA 12/2019
1	SugarsIBA 01/2019
1	Ether (Diethyl Ether)IBA 01/2018
1	benzimidazoleIBA 01/2018
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 03/2017
1	AcidsIBA 03/2017
1	plakortide EIBA 03/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2016
1	carfilzomibIBA 10/2016
1	Myeloid-Lymphoid Leukemia ProteinIBA 05/2015
1	human taspase1IBA 05/2015
1	compound FP 2IBA 09/2012
1	aziridine-2,3-dicarboxylateIBA 12/2010
1	DipeptidesIBA 07/2010
1	falcipainIBA 09/2009
1	pyrimidineIBA 07/2009
1	purineIBA 07/2009

Therapy/Procedure

6	Therapeutics 11/2023 - 09/2014
2	Drug Therapy (Chemotherapy) 01/2018 - 07/2006
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2020
1	Immunotherapy 01/2020